2-(tert-Butoxy)-2-(5-methyl-2-phenyl-7-(m-tolyl)pyrazolo-[1,5-a]pyrimidin-6-yl)acetic Acid

ID: ALA4475105

PubChem CID: 70660283

Max Phase: Preclinical

Molecular Formula: C26H27N3O3

Molecular Weight: 429.52

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cccc(-c2c(C(OC(C)(C)C)C(=O)O)c(C)nc3cc(-c4ccccc4)nn23)c1

Standard InChI:  InChI=1S/C26H27N3O3/c1-16-10-9-13-19(14-16)23-22(24(25(30)31)32-26(3,4)5)17(2)27-21-15-20(28-29(21)23)18-11-7-6-8-12-18/h6-15,24H,1-5H3,(H,30,31)

Standard InChI Key:  VLWISWDZAAGZQS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   35.8004   -5.8105    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.5179   -5.3990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5151   -4.5679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7986   -4.1564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0846   -5.3994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0859   -4.5746    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.3015   -4.3197    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.8139   -4.9830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2996   -5.6517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9882   -4.9863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5791   -4.2686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7543   -4.2670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3377   -4.9824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7559   -5.7009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5793   -5.6989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2298   -5.8084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2248   -4.1504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9419   -4.5625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6558   -4.1450    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.9450   -5.3880    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.2218   -3.3249    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.9356   -2.9115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9326   -2.0859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6527   -3.3194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6466   -2.4890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7935   -3.3361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5087   -2.9228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5011   -2.0980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7874   -1.6857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0714   -2.1082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0784   -2.9316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3564   -1.7039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  2  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 10  1  0
  2 16  1  0
  3 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 17 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 22 25  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
  4 26  1  0
 30 32  1  0
M  END

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
pol Human immunodeficiency virus type 1 integrase (9041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 429.52Molecular Weight (Monoisotopic): 429.2052AlogP: 5.62#Rotatable Bonds: 5
Polar Surface Area: 76.72Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.93CX Basic pKa: 1.37CX LogP: 5.52CX LogD: 2.32
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.45Np Likeness Score: -1.07

References

1. Li G, Meanwell NA, Krystal MR, Langley DR, Naidu BN, Sivaprakasam P, Lewis H, Kish K, Khan JA, Ng A, Trainor GL, Cianci C, Dicker IB, Walker MA, Lin Z, Protack T, Discotto L, Jenkins S, Gerritz SW, Pendri A..  (2020)  Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors.,  63  (5): [PMID:32081010] [10.1021/acs.jmedchem.9b01681]

Source